Femoston 1/5mg 28s Kit Tab
Marketer
Abbott India Ltd
Composition
Estradiol (1mg) + Dydrogesterone (5mg)
About Femoston 1/5mg 28s Kit Tab
This medication is a combination of Femoston 1/5mg 28s Kit Tab (Estradiol + Dydrogesterone), hormones that are often used to treat menopausal symptoms and prevent osteoporosis. It works by replacing the hormones that are naturally declining during menopause. While it can be very effective, it is important to be aware of the potential side effects, safety considerations, and to always follow your doctor's instructions carefully.
Frequently Asked Questions (FAQs)
What are the most common side effects of this medication?
Can I stop taking this medication suddenly?
Is this medication safe for breastfeeding women?
What if I miss a dose?
How long will it take for this medication to work?
Last Updated On 03 Jul. 2025 | 02:35 PM (IST)
Report Error
Was this Product Information helpful?
Some people found this information helpful
User Feedback
Disclaimer
We, at MedCart make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed
medicine-related information to our consumers. However, it should, by no means, be considered a
substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship.
In fact, we detest any form of self-medication without expert advice. The sole purpose of the
information on our portal is to educate our consumers, which helps improve the communication
between a doctor and a patient. The information by no means is complete in its entirety and
should not be used to diagnose or treat any medical condition. No amount of information can
replace the experience and expertise of a doctor, therefore his/her advice always holds
priority and should be followed appropriately.

5k+ people saw this product recently
MRP
₹1,417.00
10% off applied
In Stock
₹1,275.30
(₹1275.3 per unit)
For 1 Tablet (s)
Inclusive of all Taxes
Delivery Pincode
Check
Delivery in 60-90 mins
Cash on Delivery Available
Easy 7 Days Return Available
Expires on or after Dec 2024
Country of Origin: India
User Feedback